机构：[1]State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Key Lab Drug Target Res & Drug Screen, Beijing 100050, Peoples R China[3]Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Sch Med, Dept Pharm,Personalized Drug Therapy Key Lab Sichu, Chengdu 610072, Sichuan, Peoples R China四川省人民医院[4]Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, Beijing 100050, Peoples R China
第一作者机构：[1]State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Key Lab Drug Target Res & Drug Screen, Beijing 100050, Peoples R China
通讯作者：
通讯机构：[1]State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Key Lab Drug Target Res & Drug Screen, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Yizhi,Li Wan,Yang Yihui,et al.AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway (vol 24, 69, 2024)[J].CANCER CELL INTERNATIONAL.2024,24(1):doi:10.1186/s12935-024-03473-4.
APA：
Zhang, Yizhi,Li, Wan,Yang, Yihui,Zhang, Sen,Yang, Hong...&Wang, Jinhua.(2024).AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway (vol 24, 69, 2024).CANCER CELL INTERNATIONAL,24,(1)
MLA：
Zhang, Yizhi,et al."AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway (vol 24, 69, 2024)".CANCER CELL INTERNATIONAL 24..1(2024)
